Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-6,page-paged-6,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.3.0,vc_responsive

CLIENT NEWS

 

 

  • CENTOGENE AG: CENTOGENE Expands COVID-19 Testing Capacity at Frankfurt Airport
    www.centogene.com
  • France Biotech: HealthTech Innovation Days Announce Details of Conference Program & Attendees
    www.france-biotech.fr
  • Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
    www.veronapharma.com
  • Imcyse SA: Imcyse Announces the Appointment of Denis Bedoret as Chief Executive Officer
    www.imcyse.com
  • Relief Appoints Gilles Della Corte, M.D. as Chief Medical Officer
    www.relieftherapeutics.com
  • Adocia to Present Results of the 1st Phase Ib Study of M1Pram (ADO09) at the Annual Congress of the Société Francophone du Diabète (SFD)
    www.adocia.com
  • CENTOGENE AG: CENTOGENE Publishes Huge Dataset that Supports Genome Sequencing as a First-Line Diagnostic Test
    www.centogene.com
  • Abivax reports long-lasting two-year efficacy and safety data from ABX464 ulcerative colitis Phase 2a maintenance study
    www.abivax.com
  • Relief Announces Successful Up-listing from OTC Pink to OTCQB and Capital Increase from its Share Subscription Facility with GEM
    www.relieftherapeutics.com
  • Verona Pharma to Present Phase 2b data with Ensifentrine in COPD at the European Respiratory Society International Congress 2020
    www.veronapharma.com